Why PAVmed Inc.’s (PAVM) Stock Is Up 5.70%
As of Thursday, May 07, PAVmed Inc.’s PAVM share price has surged by 5.70%, which has investors questioning if this is right time to sell.Rosalio Madrigal
A+ Stock Grade Summary:
| VALUE: |
|
|
| GROWTH: |
|
|
| MOMENTUM: |
|
|
| EPS REVISIONS: |
|
|
| QUALITY: |
|
|
Rosalio Madrigal
Jenna Brashear
| Share Statistics | PAVM | Industry Median |
Percentile (All Stocks) |
|
| Market Cap (Mil) | $7.9 | $363.7 | 7% |
|
| Shares Out (Mil) | 6.6 | 41.1 | 17% |
|
| Institutional Ownership | 24.7% | 82.7% | 10% |
|
| Float (Mil) | 4.0 | 36.7 | 10% |
|
| Beta | na | 0.89 | na |
|
| Avg Daily Volume (000s) | 42 | 326 | 27% |
|
| Price Change (52-week) |
(90.2%) | 54.6% | 6% |
|
| Growth | PAVM | Industry Median |
Percentile (All Stocks) |
|
| Sales (5yr) | na | 11.8% | na |
|
| Net Income (5yr) | 15.0% | (5.8%) | 63% |
|
| EPS (5yr) | 55.6% | 10.6% | 95 |
|
| Dividends (5yr) | na | 0.0% | 0% |
|
| Cash Flow (5yr) | (65.3%) | (15.6%) | 3% |
|
| Estimates | Qtrly | Current Fiscal Year |
Next Fiscal Year |
|
| # of Estimates | 1 | 1 | 1 | |
| Current EPS | ($0.640) | ($2.330) | ($2.380) | |
| Month Ago EPS | ($0.640) | ($2.330) | ($2.380) | |
| # Rev Up | 1 | 1 | 1 | |
| # Rev Down | 0 | 0 | 0 | |
| Three Months Ago EPS | ($0.610) | ($2.620) | ($2.450) | |
| Year/Year Chg | (63.8%) | (58.6%) | (84.5%) | |
| Financials | PAVM | Industry Median |
Percentile (All Stocks) |
|
| Sales (TTM) (Mil) | $0 | $123 | 0% |
|
| Net Income (TTM) (Mil) | ($18) | ($9) | 24% |
|
| EPS (TTM) | ($4.315) | ($0.300) | 8% |
|
| Operating Cash Flow (TTM) (Mil) | ($4) | ($1) | 26% |
|
| Net Cash Flow (TTM) (Mil) | $6 | $2 | 55% |
|
| Long-Term Debt (Q1) (Mil) | $1 | $21 | 18% |
|
| Enterprise Value (Q1) (Mil) | $11 | $381 | 9% |
|
| Valuation | PAVM | Industry Median |
Percentile (All Stocks) |
|
| P/B | 0.34 | 2.41 | 8% |
|
| P/E | na | 25.5 | na |
|
| Dividend Yield | 0.0% | 0.0% | 0% |
|
| PEG (5yr hist) | na | 1.3 | na |
|
| Ratios | PAVM | Industry Median |
Percentile (All Stocks) |
|
| Gross Margin | (212.2%) | 59.5% | 1% |
|
| Net Margin | na | (5.0%) | na |
|
| ROA | (50.1%) | (10.4%) | 11% |
|
| ROE | (114.9%) | (8.4%) | 7% |
|
| Liabilities to Assets | 71.2% | 45.8% | 67% |
|
| F-Score | 4 | 4 | 33% |
|
PAVmed Inc. did not pass any screens on 11/20/2026.
Price and market data provided by QuoteMedia and delayed a minimum of 15 minutes unless otherwise indicated. Fundamental data provided by AAII's Stock Investor Pro and S&P Global Market Intelligence and are updated through the previous trading day.
Ⓒ 2026 American Association of Individual Investors